Empagliflozin - Isotope Labelled Standards
References
FAQ's
References
- Eckhardt, Matthias; Eickelmann, Peter; Himmelsbach, Frank; Barsoumian, Edward Leon; Thomas, Leo, Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture, Boehringer Ingelheim International GmbH, Germany, US7579449B2, August 25, 2009
- Padmaja, N.; Veerabhadram, G., Development and validation of a novel stability-indicating RP-HPLC method for the determination of empagliflozin in bulk and pharmaceutical dosage form, International Journal of Pharmaceutical Sciences and Research, Volume: 7, Issue: 11, Pages: 4523-4530, 2016
Frequently Asked Questions
How are Empagliflozin impurities analyzed?
Analytical methods such as high-performance liquid chromatography (HPLC) and mass spectrometry help analyze and detect Empagliflozin impurities.
How are Empagliflozin impurities controlled during manufacturing?
Strict control measures, including process optimization, purification steps, and monitoring, are implemented during the manufacturing process to minimize impurity formation and maintain the quality of Empagliflozin.
What solvent help in analyzing Empagliflozin impurities?
Methanol or Acetonitrile are the solvents used for analyzing many impurities in Empagliflozin.
How should Empagliflozin impurities be stored in terms of temperature?
Empagliflozin impurities are stored at a controlled room temperature, between 2-8 ⁰C, or according to the specifications provided on the Certificate of Analysis (CoA).
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.